Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_assertion description "[In clinical samples, EphA5 methylation was detected in 64.1% (75/117) of breast tumors and 28.2% (33/117) of paired normal tissues (P < .001), which was associated with higher tumor grade (P = .024), lymph node metastasis (P = .004), and progesterone receptor-negative status (P = .008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_assertion evidence source_evidence_literature NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_assertion SIO_000772 19733895 NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_assertion wasDerivedFrom befree-20140225 NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_assertion wasGeneratedBy ECO_0000203 NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP207571.RA1X6iiwmnBKiCUCDGxm8j2eHN29g2iq7z-Z5o5GTWGFQ130_provenance.